CELC
CELC
NASDAQ · Biotechnology

Celcuity Inc

$84.00
+3.39 (+4.21%)
As of Sep 21, 9:53 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -69.6% upside
Low Target $16.07
Average Target $25.56
High Target $38.64
Current Price $84.00
Current
$84.00
Target
$25.56
$16.07 $25.56 avg $38.64
Scenario Analysis
Bear Case
$16.07
-80.9%
Low target
Base Case
$25.56
-69.6%
Avg target
Bull Case
$38.64
+-54.0%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$151.02
-44.4% from high
52-Week Low
$44.42
+89.1% from low
50-Day SMA
$105.59
-20.4% vs SMA
200-Day SMA
$59.11
+42.1% vs SMA
RSI (14)
39.6
Neutral
Target vs 52W High
$25.56
-83.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%